← Back
Data updated: Mar 10, 2026
QUANTUM PHARMICS
NeurologyCardiovascular
QUANTUM PHARMICS is a generic drug manufacturer focused on Neurology, Cardiovascular.
1985
Since
25
Drugs
-
Trials
133
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
TRAZODONE HYDROCHLORIDE 2026-02-09
Labeling
TRAZODONE HYDROCHLORIDE 2026-02-09
Labeling
NYSTATIN 2026-02-05
HALOPERIDOL 2025-12-18
HYDROXYZINE HYDROCHLORIDE 2025-12-16
TRIAMTERENE AND HYDROCHLOROTHIAZIDE 2025-10-21
Labeling
TRIAMTERENE AND HYDROCHLOROTHIAZIDE 2025-10-21
Labeling
CLORAZEPATE DIPOTASSIUM 2025-08-21
Labeling
CLORAZEPATE DIPOTASSIUM 2025-08-21
Labeling
CLORAZEPATE DIPOTASSIUM 2025-08-21
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Neurology 50%
2 drugs
Cardiovascular 50%
2 drugs
Pipeline Strength Pro
Loading...
Active (5)
Discontinued (20)
TRAZODONE HYDROCHLORIDE HALOPERIDOL HYDROXYZINE HYDROCHLORIDE CLORAZEPATE DIPOTASSIUM HYDRALAZINE HYDROCHLORIDE BUTALBITAL, ASPIRIN AND CAFFEINE FENOPROFEN CALCIUM OXYBUTYNIN CHLORIDE DOXYLAMINE SUCCINATE ZAXOPAM MINODYL TRIALODINE Q-PAM CLOPRA-"YELLOW" Q-GESIC CLOPRA TEMAZ LORAZ MECLODIUM PHENTERMINE RESIN 30
Company Info
- First Approval
- 1985-10-28
- Latest
- 1989-06-28
- Applications
- 63